Kevin José Cruz-Mora

Dr. Kevin José Cruz-Mora

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
BSBruno Serrano-Arias
Bruno Serrano-Arias
AAAdriana Araya-Zúñiga
Adriana Araya-Zúñiga
JWJohan Waterhouse-Garbanzo
Johan Waterhouse-Garbanzo
ZRZoe Rojas-Barrantes
Zoe Rojas-Barrantes
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
KCKevin José Cruz-Mora
Kevin José Cruz-Mora

21 May 2025 in Dermato
Verified
Journal Article
Open access
PDF file
EMErnesto Martínez-Vargas
Ernesto Martínez-Vargas
JMJeaustin Arón Mora
Jeaustin Arón Mora
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
JHJosephine Hernández-López
Josephine Hernández-López
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
Background: Artificial intelligence (AI) has emerged as a transformative tool in modern medicine, particularly in dermatology, where it supports the diagnosis and management of various skin diseases, including skin cancer. Through machine learning and deep learning techniques, AI enables accurate analysis of clinical and dermoscopic images, improving early detection and clinical outcomes. Objective: This systematic review aimed to evaluate the clinical applications of AI in dermatology, focusing on its impact on diagnostic accuracy, workflow efficiency, and access to specialized care. Methods: The review was conducted according to PRISMA guidelines. Peer-reviewed studies published between January 2020 and March 2025 in English or Spanish were included if they evaluated AI-based tools for dermatological diagnosis, classification, or treatment. Animal studies, editorials, non-peer-reviewed articles, and studies with an unclear methodology were excluded. A comprehensive search was performed in PubMed, Scopus, IEEE Xplore, and Google Scholar between December 2024 and March 2025. The risk of bias was assessed qualitatively, using a tailored framework based on study design, dataset transparency, and clinical applicability. Results: A total of 29 studies met the inclusion criteria. AI tools demonstrated high performance in melanoma detection, achieving up to 90% accuracy and 85% sensitivity. In clinical settings, AI support reduced mismanagement of malignant lesions from 58.8% to 4.1% and avoided 27% of unnecessary procedures in benign cases. Additional tools such as convolutional neural networks and imaging systems like FotoFinder also showed promising results. Limitations: Limitations of the evidence include the heterogeneity of AI models, lack of external validation, and a moderate-to-high risk of bias. Conclusions: AI has demonstrated robust clinical potential in dermatology, particularly in cancer detection and workflow optimization. However, further studies are required to address challenges such as algorithmic bias, data privacy, and regulatory oversight. Funding and registration: This review received no external funding and was not registered in a systematic review registry.

25 January 2025 in Cureus
Verified
Journal Article
Open access
PDF file
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
CRCarolina Rojas-Chinchilla
Carolina Rojas-Chinchilla
PMPaula Molina-Sojo
Paula Molina-Sojo
MMMaria Fernanda Murillo-Castro
Maria Fernanda Murillo-Castro
JRJose Pablo Rojas-Molina
Jose Pablo Rojas-Molina
EMErnesto Martínez-Vargas
Ernesto Martínez-Vargas
Climate change has significantly altered the dynamics of vector-borne infectious diseases, favoring their proliferation and geographic expansion. Factors such as rising temperatures, the frequency of extreme weather events, and uncontrolled urbanization have increased the incidence of diseases such as dengue, Zika, chikungunya, malaria, and Lyme disease, especially in vulnerable regions with limited infrastructure. This article presents a narrative review based on recent scientific literature (2018-2025) to assess the impact of climate change on vector distribution, co-infections, and control strategies. The evidence collected highlights how changing climate conditions, combined with socioeconomic, political, and demographic factors, exacerbate public health crises and complicate mitigation efforts. It is concluded that facing this challenge requires a comprehensive strategy that combines environmental management, technological innovation, epidemiological surveillance, and community educational programs, promoting a coordinated global response to reduce the associated risks.

3 June 2024 in Cureus
Verified
Journal Article
Open access
PDF file
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
RQRicardo Quesada-Villaseñor
Ricardo Quesada-Villaseñor
SASebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
JGJonathan García-Montero
Jonathan García-Montero
MBMonserrat Barrantes-López
Monserrat Barrantes-López
DDDaniel E Diaz-Juan
Daniel E Diaz-Juan
Qure.AI, a leading company in artificial intelligence (AI) applied to healthcare, has developed a suite of innovative solutions to revolutionize medical diagnosis and treatment. With a plethora of FDA-approved tools for clinical use, Qure.AI continually strives for innovation in integrating AI into healthcare systems. This article delves into the efficacy of Qure.AI’s chest X-ray interpretation tool, "qXR," in medicine, drawing from a comprehensive review of clinical trials conducted by various institutions. Key applications of AI in healthcare include machine learning, deep learning, and natural language processing (NLP), all of which contribute to enhanced diagnostic accuracy, efficiency, and speed. Through the analysis of vast datasets, AI algorithms assist physicians in interpreting medical data and making informed decisions, thereby improving patient care outcomes. Illustrative examples highlight AI's impact on medical imaging, particularly in the diagnosis of conditions such as breast cancer, heart failure, and pulmonary nodules. AI can significantly reduce diagnostic errors and expedite the interpretation of medical images, leading to more timely interventions and treatments. Furthermore, AI-powered predictive analytics enable early detection of diseases and facilitate personalized treatment plans, thereby reducing healthcare costs and improving patient outcomes. The efficacy of AI in healthcare is underscored by its ability to complement traditional diagnostic methods, providing physicians with valuable insights and support in clinical decision-making. As AI continues to evolve, its role in patient care and medical research is poised to expand, promising further advancements in diagnostic accuracy and treatment efficacy.

1 January 2024 in International Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
AQAlonso Quirós-Romero
Alonso Quirós-Romero
Jose Miguel Chaverri-FernandezJose Miguel Chaverri-Fernandez
Jose Miguel Chaverri-Fernandez
BSBruno Serrano-Arias
Bruno Serrano-Arias
MSMario Speranza
Mario Speranza
Zavaleta-Monestel E, et al. Int J Heart Fail. 2024 Jan;6(1):1-10. https://doi.org/10.36628/ijhf.2023.0022

3 February 2025 in Cureus
Verified
Journal Article
Open access
PDF file
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
AAAdriana Anchía-Alfaro
Adriana Anchía-Alfaro
CRCarolina Rojas-Chinchilla
Carolina Rojas-Chinchilla
DQDiego Fabian Quesada-Loria
Diego Fabian Quesada-Loria
SASebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
Introduction Artificial intelligence (AI) transforms medicine by enhancing diagnoses, treatments, resource management, and personalized treatment plans. However, it poses ethical and legal challenges, such as data privacy and equitable access to its benefits. This study seeks to understand healthcare professionals' perceptions of AI regulation in a Costa Rican hospital and analyze the alignment of Latin American regulations with local realities. Methods The research is qualitative, descriptive, and cross-sectional, focusing on AI guidelines and laws in health at both international and national levels. The sample includes healthcare professionals from a private hospital in Costa Rica. Two instruments were used: a documentary review and an online survey. Data analysis was performed using descriptive and correlational statistics with RStudio (R Foundation for Statistical Computing, Vienna, Austria (https://www.R-project.org/)). Results Eighty healthcare professionals participated in the study. Findings revealed that most exhibited moderate familiarity with AI while underscoring the critical need for robust governance frameworks to navigate the ethical and regulatory complexities surrounding its implementation. Notably, no significant correlation emerged between AI familiarity and demographic factors. Limitations of this study include its focus on a single hospital and the heterogeneous regulatory landscape across Latin American countries. Conclusions The study reveals that the integration of AI in healthcare is promising but complex, requiring a multidimensional approach that includes technical, ethical, and social aspects. Healthcare professionals in Costa Rica show a favorable disposition towards AI, recognizing its potential to improve healthcare, although they also highlight concerns about data privacy, security, and ethics.